Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank64
5Y CAGR-0.9%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-0.9%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202515.40%
2024-25.61%
202320.64%
2022-5.63%
2021-31.64%
202016.08%
201913.25%
2018-125.59%
2017-34.74%
2016-377.27%